The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.

康复之路：对马拉维癌症幸存者患者报告的生活质量的评估。

• 批准号: 10428019
• 负责人: Carla J Chibwesha
• 金额: $ 19.06万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-13 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10428019
• 关键词: Administrative Supplement; Aftercare; Cancer Control; Cancer Survivor; Cancer Survivorship; Cohort Studies; Country; Diagnosis; Early Diagnosis; Enrollment; Equilibrium; Goals; Individual; Intervention; Kaposi Sarcoma; Life; Lymphoma; Malawi; Malignant Neoplasms; Measures; Mental Health; Outcome; Patient Outcomes Assessments; Patients; Physical Function; Population; Quality of life; Recovery; Reporting; Resources; Survivors; Time; Translating; cancer care; cancer survival; cancer therapy; cancer type; comparison group; experience; health related quality of life; improved; patient oriented; prospective; survivorship

PROJECT SUMMARY/ABSTRACT: Increasing efforts to improve early detection, diagnosis, and treatment of cancers in low resourced countries have led to modest improvements in cancer survival and given rise to an expanding population of cancer survivors. However, there is a gap in the understanding of cancer survivorship in low resourced countries. The goal of this proposal is to measure health-related quality of life (HRQoL) for cancer survivors with Kaposi sarcoma (KS) and lymphoma across the continuum of cancer care in Malawi. In line with NCI's definition of a cancer survivor, our survivor population includes any individual diagnosed with cancer from the time of diagnosis through the balance of life. We hypothesize that: a) KS and lymphoma survivors will have differences in mental health and physical function domains of HRQoL before (pre-), during (mid-), and up to 1 year after (post-) cancer-directed treatment; and b) there is no difference in post-treatment HRQoL among short-term (< 1 year since treatment completion), medium-term (≥1-5 years since treatment completion) or long-term (> 5 year since treatment completion) survivors.

项目摘要/摘要： 越来越多地改善低资源国家的癌症的早期检测，诊断和治疗 导致癌症生存的适度改善，并导致癌症人群不断增加 幸存者。但是，了解低源国家的癌症生存阶段存在差距。这 该建议的目标是测量与Kaposi的癌症存活的与健康相关的生活质量（HRQOL） 马拉维癌症治疗连续性的肉瘤（KS）和淋巴瘤。符合NCI的定义 癌症幸存者，我们的幸存者人口包括从 通过生活平衡诊断。我们假设：a）KS和淋巴瘤冲浪者会有差异 在（前），（中）和之后最多1年的HRQOL的心理健康和身体功能领域 （后）癌症指导的治疗； b）短期治疗后HRQOL没有差异（< 自治疗完成以来1年），中期（≥1-5岁以来治疗完成）或长期（> 5） 自治疗完成以来的一年）生存。